Brown Technology Innovations
Innovation@Brown Showcase
The Innovation@Brown Showcase celebrates local innovation and provides an opportunity to network with investors, academic researchers, entrepreneurs and regional leaders and learn more about the growing ecosystem around Brown.
Innovation@Brown Showcase
The Innovation@Brown Showcase celebrates local innovation and provides an opportunity to network with investors, academic researchers, entrepreneurs and regional leaders and learn more about the growing ecosystem around Brown.
2025 Innovation@Brown Showcase
Registration is live!
Brown Technology Innovations invites you to join us during Rhode Island Startup Week for the third annual Innovation@Brown Showcase!
September 25, 2025 | 2-6 p.m.
CIC Providence
225 Dyer Street, Providence, R.I.
The third annual Innovation@Brown Showcase, hosted by Brown Technology Innovations (BTI), is a celebration of local innovation in and around Brown University. The agenda includes an awards ceremony recognizing BTI’s Inventor of the Year, Startup of the Year, and Innovation of the Year, and a showcase of 20-25 Brown-affiliated ventures. A key part of Rhode Island Startup Week, this is a can’t-miss event for investors, academic researchers, entrepreneurs and industry leaders. Past years have drawn over 300 attendees, so secure your spot early!
Featured Ventures
Acre TherapeuticsAcre Therapeutics is harnessing antisense oligonucleotide technology to target an Alzheimer’s disease risk factor. This represents a novel precision medicine approach which aims to prevent or delay the onset of dementia in Alzheimer’s and other tau-driven neurodegenerative diseases. | CareCrowdCareCrowd is a healthcare data management platform transforming how provider data is collected, validated, and accessed. We combine automated data scraping with real-time crowdsourced data inputs and updates to build the most accurate and up-to-date healthcare provider directory on the market. Our platform addresses the costly and time-consuming problem of inaccurate directories, which burden insurers and hinder efficient patient referrals. Currently deployed in large practices across Massachusetts and Rhode Island, CareCrowd is already enhancing workflow efficiency and data quality for care teams. |
ChronoSpace AIChronoSpace AI is building the world's first geometry-native AI model of reality. | Ember Therapeutics CorporationEmber develops and evaluates digital health monitoring and intervention tools that integrate wearable biosensors, ecological momentary assessment, and provider-facing platforms to deliver personalized, real-time support for substance use treatment and prevention. Our products leverage technology to capture dynamic risk states and reduce bias in clinical decision-making, to improve outcomes for individuals during critical periods of vulnerability. |
EndoSwim SolutionsWe're a deep tech company pioneering wireless swimming robotic systems that navigate viscous fluid environments with precision. Building on our proprietary bio-inspired propulsion technology, we develop breakthrough platforms for medical diagnostics, industrial inspection, food sanitization and beyond. | EnkaBiologics Inc.EnkaBiologics Inc., founded by Drs. Chathuraka Jayasuriya and Jay Trivedi, is developing innovative cell-based biologic therapeutics to effectively treat musculoskeletal injuries beyond the current standard of care. |
Kyron MedicalKyron Medical is a medical billing company staffed entirely by AI agents. It offers a proprietary voice AI dashboard that ensures humans never have to wait on hold when calling health insurance. The company has been featured on NBC News and by Medicine@Brown, and has customers across multiple states in the US. | GeroSenGeroSen Biotechnologies is a Rhode Island–based life sciences company specializing in advanced analytical solutions for the detection and characterization of senescent cells. Our technology enables researchers and industry partners to better understand cellular aging and supports applications in aging research, diagnostics, and regenerative medicine. |
EnzylockEnzylock’s platform wound dressing technology is engineered to reduce chronic wound infection rates and minimize unnecessary antibiotic use, thereby mitigating antimicrobial resistance and enabling more effective healing. The dressing activates only in the presence of bacteria-specific enzymes, releasing targeted antimicrobial therapy to accelerate recovery and improve patient outcomes. | Fermi EnergyFermi Energy develops and manufactures high-performance cathode materials for lithium-ion batteries in the U.S. Our proprietary low-temperature calcination process is scalable and dramatically reduces energy use compared to conventional methods, enabling cost-effective and sustainable domestic production. This approach strengthens U.S. supply chains while lowering the environmental footprint of battery manufacturing. |
Lilac Biosciences Inc.Lilac is pioneering innovative kits and assays to detect and quantify specific RNA modifications critical for advancing research and therapeutic discovery. Lilac aims to expand access to next-generation RNA analysis tools designed for both academic and industry researchers, accelerating breakthroughs in areas such as cancer, neurodegenerative diseases, and RNA-based therapeutics. | NematexNematex is the first biological solution to sterilise Root Knot Nematodes (RKN) in a safe and hyper targeted manner at scale. |
Nereus SystemsNereus is the first autonomous metachronal robotic platform with swarming and high-motility capabilities for spatially-extensive, cost-effective, underwater survey missions. | PyraSim SolutionsPyraSim Solutions develops brain simulations to accelerate drug discovery and personalize neuropsychiatric care. Using computational models for non-invasive neural biomarkers, our platform is designed to help drug developers validate next-generation therapies for conditions like schizophrenia and depression and clinicians optimize treatment decisions. We're transforming the neuropharmaceutical industry and mental healthcare from trial-and-error approaches to personalized, objective treatments. |
Reach Neuro, Inc.Reach Neuro is redefining stroke recovery with Avantis, the first implanted neuromodulation system designed to restore voluntary movement after stroke-induced paralysis. By targeting sensory nerves in the cervical spinal cord, our therapy reactivates natural motor control—helping patients regain the ability to use their arms and hands. Backed by early clinical success, Reach Neuro is unlocking a new standard of care for millions living with post-stroke disability. | SomaCareChronic pain affects nearly 1 in 4 adults and remains one of the most costly, complex challenges in healthcare. Its multidimensional nature and lack of reliable biomarkers leave treatments reactive, generic, and often ineffective. SomaCare changes this by combining real-time symptom tracking, wearable data, and neuroscience-based tools in an AI-powered platform that delivers personalized, scalable interventions to reduce healthcare costs and burden while empowering patients with effective, individualized care. |
TEEM TherapeuticsTEEM Therapeutics is pioneering precision medicine for cardiac disease to discover novel drug targets and develop new therapies. Our patented technology leverages patient-specific 3D human heart tissue-engineered models, advanced sensor arrays, and automated analytics to accelerate drug discovery. We are positioned to set a new standard in cardiac drug development and improve outcomes for conditions like atrial fibrillation. |
Past Showcases
https://www.youtube.com/embed/1SbzrU57Gt0
BTI’s annual Innovation@Brown Showcase highlights local startup activity, celebrates groundbreaking inventions, and offers networking opportunities.
The second annual Innovation@Brown Showcase featured representatives from 24 Brown-affiliated companies and awards for Innovation of the Year, Inventor of the Year, and Startup of the Year.
The inaugural Innovation@Brown Showcase, held at Venture Café Providence, featured 25 early-stage startups led by Brown faculty, students and alumni.